Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Cell-Cycle Position of Single MYC-Driven Cancer Cells Dictates Their Susceptibility to a Chemotherapeutic Drug.

Ryl T, Kuchen EE, Bell E, Shao C, Flórez AF, Mönke G, Gogolin S, Friedrich M, Lamprecht F, Westermann F, Höfer T.

Cell Syst. 2017 Sep 27;5(3):237-250.e8. doi: 10.1016/j.cels.2017.07.005. Epub 2017 Aug 23.

2.

Large-scale tracking and classification for automatic analysis of cell migration and proliferation, and experimental optimization of high-throughput screens of neuroblastoma cells.

Harder N, Batra R, Diessl N, Gogolin S, Eils R, Westermann F, König R, Rohr K.

Cytometry A. 2015 Jun;87(6):524-40. doi: 10.1002/cyto.a.22632. Epub 2015 Jan 28.

3.

CDK4 inhibition restores G(1)-S arrest in MYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage.

Gogolin S, Ehemann V, Becker G, Brueckner LM, Dreidax D, Bannert S, Nolte I, Savelyeva L, Bell E, Westermann F.

Cell Cycle. 2013 Apr 1;12(7):1091-104. doi: 10.4161/cc.24091. Epub 2013 Mar 5.

4.

Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis.

Dreidax D, Gogolin S, Schroeder C, Muth D, Brueckner LM, Hess EM, Zapatka M, Theißen J, Fischer M, Ehemann V, Schwab M, Savelyeva L, Westermann F.

Hum Mol Genet. 2013 May 1;22(9):1735-45. doi: 10.1093/hmg/ddt020. Epub 2013 Jan 23.

PMID:
23343716
5.

Time-lapse imaging of neuroblastoma cells to determine cell fate upon gene knockdown.

Batra R, Harder N, Gogolin S, Diessl N, Soons Z, Jäger-Schmidt C, Lawerenz C, Eils R, Rohr K, Westermann F, König R.

PLoS One. 2012;7(12):e50988. doi: 10.1371/journal.pone.0050988. Epub 2012 Dec 12.

6.

MYCN-mediated overexpression of mitotic spindle regulatory genes and loss of p53-p21 function jointly support the survival of tetraploid neuroblastoma cells.

Gogolin S, Batra R, Harder N, Ehemann V, Paffhausen T, Diessl N, Sagulenko V, Benner A, Gade S, Nolte I, Rohr K, König R, Westermann F.

Cancer Lett. 2013 Apr 30;331(1):35-45. doi: 10.1016/j.canlet.2012.11.028. Epub 2012 Nov 24.

PMID:
23186832
7.

CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiation programs in neuroblastoma cells.

Henrich KO, Bauer T, Schulte J, Ehemann V, Deubzer H, Gogolin S, Muth D, Fischer M, Benner A, König R, Schwab M, Westermann F.

Cancer Res. 2011 Apr 15;71(8):3142-51. doi: 10.1158/0008-5472.CAN-10-3014. Epub 2011 Mar 8.

8.

MYCN/MYC-mediated drug resistance mechanisms in neuroblastoma.

Gogolin S, Dreidax D, Becker G, Ehemann V, Schwab M, Westermann F.

Int J Clin Pharmacol Ther. 2010 Jul;48(7):489-91. No abstract available.

PMID:
20557856
9.

Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma.

Muth D, Ghazaryan S, Eckerle I, Beckett E, Pöhler C, Batzler J, Beisel C, Gogolin S, Fischer M, Henrich KO, Ehemann V, Gillespie P, Schwab M, Westermann F.

Cancer Res. 2010 May 1;70(9):3791-802. doi: 10.1158/0008-5472.CAN-09-1245. Epub 2010 Apr 27.

10.

[Development of a tray system for orthodontic technic].

Gogolin S.

Zahntechnik (Berl). 1979 Dec;20(12):490-502. German. No abstract available.

PMID:
298153
11.

[Rational polishing technic with a polishing drum].

Gogolin S.

Zahntechnik (Berl). 1978 Nov;19(11):511. German. No abstract available.

PMID:
294025

Supplemental Content

Loading ...
Support Center